Our founder, the late Dr Anji Reddy, chose to call his memoirs An Unfinished Agenda-the unfinished part being the discovery, development and commercialisation of a new drug by Dr. Reddy's in his time. While our company initiated new drug discovery in 1992, the cost and risks of going beyond early-stage discovery were prohibitive to the young company.
It was Dr Anji Reddy's dream to see Indian pharma successfully discover and take a pipeline of new molecules to the market and become an original innovation-driven industry.
Global manufacturing prowess: Today, India is the largest provider of generic drugs globally. Indian pharma supplies over 50 per cent of the global demand for various vaccines, 40 per cent of the generic demand in the US and 25 per cent of all medicines in the UK. Globally, India ranks third in terms of pharmaceutical production by volume and 14th by value.
We built world-class capabilities in bulk drugs or API (Active Pharmaceutical Ingredients) in the mid-20th century, turning our attention to formulations and newer dosage forms in the 1990s, and entering new markets to break new frontiers internationally. We moved up the value chain in complexity from simple to complex molecules with higher entry barriers, cutting-edge technology platforms, devices, new chemical entities, biosimilars and biologics.
The Indian pharma industry is known as the 'pharmacy of the world' thanks to its manufacturing prowess, and stands for affordability, access, agility and quality.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
A Life IN MUSIC
To celebrate five decades of a storied musical career, Padma Shri Hariharan is headlining a special concert in Delhi on November 30
MURDERS MOST FOUL
SAMYUKTA BHOWMICK'S DEBUT NOVEL, A FATAL DISTRACTION, IS A WHODUNIT THAT GOES BEYOND MERELY PAYING TRIBUTE TO THE MASTERS OF THE GENRE
Jungle Book
Avtar Singh creates a compelling tableau of characters brought together and torn asunder by migration, epidemic and circumstance
BON VOYAGE
The award-winning stage adaptation of Yann Martel's Life of Pi is coming to Mumbai this December
Earning His ACTING CHOPS
HIS LATEST STINT IN THE BUCKINGHAM MURDERS, WHICH JUST RELEASED ON NETFLIX, CEMENTS THE MULTI-HYPHENATE RANVEER BRAR'S REPUTATION AS A FINE ACTOR
Strike a Pose
SOONI TARAPOREVALA'S SERIES DEBUT WAACK GIRLS ON PRIME VIDEO SHINES A LIGHT ON THE STREET DANCE STYLE OF WAACKING
FATAL ATTRACTION
In I Want to Talk, Shoojit Sircar continues his exploration of death with the portrait of a tenacious man who beats it time and again
LOVE LETTER TO THE MOUNTAINS
'Journeying Across the Himalayas' is a new multidisciplinary festival in Delhi with a focus on the Himalayan region and its communities
The Art of CURATION
Sunil Kant Munjal, founder patron of the Serendipity Arts Foundation, on how one of our biggest multi-disciplinary festivals came about and what to look forward to in this edition
THE ROCKY ROAD AHEAD
A US court's allegations of bribery in solar power contracts and US markets watchdog SEC's charges of concealing wrongdoings have jolted Gautam Adani's business empire. Even as he mounts a strong defence against the indictment, the group faces a crisis of investor confidence that may impact its growth plans